Annual Statement of Changes in Beneficial Ownership (5)
November 05 2021 - 5:01PM
Edgar (US Regulatory)
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ]
Form 3 Holdings Reported
[X]
Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0362
Estimated average burden hours per response...
1.0
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
BEPLATE DOUGLAS K | 2. Issuer Name and Ticker or Trading SymbolUnited Health Products, Inc. [UEEC] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O UNITED HEALTH PRODUCTS, INC., 10624 S. EASTERN AVE., STE. A209 | 3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY) 12/31/2018 |
(Street)
HENDERSON, NV 89052
(City)
(State)
(Zip)
| 4. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any | 3. Trans. Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) |
Amount | (A) or (D) | Price |
Common Stock (1) | 1/10/2018 | | G4 | 150000 | D | $0.00 (2) | 4740253 | D | |
Common Stock (1) | 4/10/2018 | | G4 | 200000 | D | $0.00 (2) | 4540253 | D | |
Common Stock (1) | 4/18/2018 | | G4 | 225253 | D | $0.00 (2) | 4365000 | D | |
Common Stock (1) | 5/4/2018 | | S4 | 148653 | D | $0.69 | 4216447 | D | |
Common Stock (1) | 6/14/2018 | | W4 | 1512000 | A | $0.00 (3) | 5728447 | D | |
Common Stock (1) | 6/14/2018 | | G4 | 46750 | D | $0.00 (2) | 5681697 | D | |
Common Stock (1) | 7/10/2018 | | G4 | 243650 | D | $0.00 (2) | 5438047 | D | |
Common Stock (1) | 8/6/2018 | | S4 | 300000 | D | $0.33 | 5138047 | D | |
Common Stock (1) | 9/17/2018 | | G4 | 1000000 | D | $0.00 (2) | 4138047 | D | |
Common Stock (1) | 10/25/2018 | | G4 | 240000 | D | $0.00 (2) | 3898047 | D | |
Common Stock (1) | 10/31/2018 | | G4 | 100000 | D | $0.00 (2) | 3798047 | D | |
Common Stock (1) | 11/29/2018 | | S4 | 400000 | D | $0.50 | 3398047 | D | |
Common Stock (1) | 12/11/2018 | | S4 | 90000 | D | $0.50 | 3308047 | D | |
Common Stock (1) | 12/17/2018 | | S4 | 555000 | D | $0.50 | 2753047 | D | |
Common Stock (1) | 12/17/2018 | | G4 | 40000 | D | $0.00 (2) | 2713047 | D | |
Common Stock (1) | 12/19/2018 | | G4 | 209000 | D | $0.00 (2) | 2504047 | D | |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (MM/DD/YYYY) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
(A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | Excludes shares of common stock owned by his spouse and other adult family members. |
(2) | Shares were gifted and no price per share was received by Mr. Beplate. |
(3) | Shares were inherited from his stepdad. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
BEPLATE DOUGLAS K C/O UNITED HEALTH PRODUCTS, INC. 10624 S. EASTERN AVE., STE. A209 HENDERSON, NV 89052 | X | X |
|
|
Signatures
|
/s/ Douglas Beplate | | 11/5/2021 |
**Signature of Reporting Person | Date |
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Apr 2023 to Apr 2024